SMARCA4 and breast carcinoma: Our Kaplan-Meier analyses demonstrated that increased BRG1 expression is significant correlated with a poorer 5-year overall and disease-specific patient survival in breast cancer, suggesting that elevated BRG1 expression may serve as a molecular prognostic marker for this disease.